Park Ha Biological Technology Co., Ltd. priced its initial public offering at $0.11 a share, to list on the Nasdaq Capital Market under the symbol BYAH. It filed a Form F-1 registration statement for an initial public offering on August 26, 2024. As of November 6, 2026, its final prospectus is on file (Form 424B4, January 28, 2026).
Sell to companies like Park Ha Biological Technology Co., Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement amended (foreign issuer) · F-1/A
- · What it is: Registration statement amended (foreign issuer) · F-1/A
- · What it is: Registration statement amended (foreign issuer) · F-1/A
- · What it is: Registration statement filed (foreign issuer) · F-1
Park Ha Biological Technology Co., Ltd. filed a Form F-1 registration statement for an initial public offering on 2024-08-26. It has amended it 8 times. It filed its final prospectus on 2026-01-28, at a public offering price of $0.11 per share. Each fact below is quoted from the filing named with it.
Also on the record for Park Ha Biological Technology Co., Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 13, 2026 | Stake report, Schedule 13G, by Motovance Holdings Limited | 9.7% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Corin Global Partners Holdings Limited | 9.8% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Fusen Advertising Design Limited | 9.8% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Nexera Technology Company Limited | 9.1% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Peverel Summit Holdings Limited | 9.8% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by PINNACLE INTERNATIONAL HOLDING LIMITED | 7.6% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Rove Trading Co., Limited | 9.8% of the class | 5%+ stakes | Source |
| August 10, 2026 | Stake report, Schedule 13G, by Velociti Group Limited | 9.8% of the class | 5%+ stakes | Source |
Check before you invest in Park Ha Biological Technology Co., Ltd.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Park Ha Biological Technology Co., Ltd. and the records around it.
Park Ha Biological Technology Co., Ltd. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Also filing to list on the Nasdaq Capital Market
IPO filings on the Nasdaq Capital Market in Q1 2026, newest first.
- FARLONG HOLDING Corp (Mar 2026)
- Innovation Beverage Group Ltd (Mar 2026)
Watch Park Ha Biological Technology Co., Ltd.
Get an email when Park Ha Biological Technology Co., Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Park Ha Biological Technology Co., Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Park Ha Biological Technology Co., Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Park Ha Biological Technology Co., Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
What the filings say
Listing
Our Class A Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “BYAH”.From the 424B4 filed 2026-01-28
Shares offered
We are offering on a best -efforts basis 21,875,000 units (the “Units”), with each Unit consisting of (i) one class A ordinary share, par value $0.00002 per share (each, a “Class A Ordinary Share,”) and collectively, the “Class A Ordinary Share”) and (ii) one warrant to purchase one Class A Ordinary Share (up to nine Class A Ordinary Shares pursuant to the zero exercise price option as described further below) (each, a “Warrant,” and collectively, the “Warrants”).From the 424B4 filed 2026-01-28
Offering price
We are offering the Units at the public offering price of $0.112 per Unit.From the 424B4 filed 2026-01-28
Use of proceeds
We currently intend to use the net proceeds to us from this offering for the expansion in directly operated stores.From the 424B4 filed 2026-01-28
Revenue
Our total revenue increased by $386,269 to $1,239,197 for the six months ended April 30, 2025 from $852,928 for the six months ended April 30, 2024.From the F-1/A filed 2025-12-05
Net loss or income
We recorded net loss of $19,835,994 for the six months ended April 30, 2025 and net income of $48,900 for the six months ended April 30, 2024.From the F-1/A filed 2025-12-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-08-26 | Registration statement filed (foreign issuer) | F-1 |
| 2024-09-18 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-10-09 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-11-06 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-06 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-20 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-12-27 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-09-19 | Registration statement filed (foreign issuer) | F-1 |
| 2025-09-25 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-12-05 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-01-23 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-01-28 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Park Ha Biological Technology Co., Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.